XML 36 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
 3 Months Ended
Jul. 31, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Andrew Anagnost [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 29, 2026, Andrew Anagnost, our President and Chief Executive Officer terminated his pre-existing Rule 10b5-1 trading arrangement adopted on August 29, 2025 providing for the sale from time to time of an aggregate of up to 93,097 shares of our common stock.
On June 23, 2026, Mr. Anagnost, adopted a new Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 66,394 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until July 1, 2027, or earlier if all transactions under the trading arrangement are completed.
Andrew Anagnost August 2025 Plan [Member] | Andrew Anagnost [Member]  
Trading Arrangements, by Individual  
Name Andrew Anagnost
Title President and Chief Executive Officer
Rule 10b5-1 Arrangement Terminated true
Termination Date May 29, 2026
Aggregate Available 93,097
Andrew Anagnost June 2026 Plan [Member] | Andrew Anagnost [Member]  
Trading Arrangements, by Individual  
Name Andrew Anagnost
Title President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 23, 2026
Expiration Date July 1, 2027
Arrangement Duration 373 days
Aggregate Available 66,394